| Financial Year |
March 31 2023 |
| Monetary Funds |
1,492,199,364.95 |
| Held-for-trading Financial Assets |
468,279,876.71 |
| Notes Receivable |
2,819,494.65 |
| Accounts Receivable |
1,357,604,785.20 |
| Advances to Suppliers |
104,746,224.24 |
| Other Receivables |
14,936,829.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,653,545,717.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
840,145,497.67 |
| Total Current Assets |
7,588,464,238.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
908,849,052.70 |
| Investment Properties |
-- |
| Fixed Assetes |
2,912,371,630.38 |
| Under-construction Projects |
1,482,233,959.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
866,573,952.50 |
| R&D expenses |
-- |
| Goodwill |
9,375,425.41 |
| Long-Term Deferred and Prepaid Expenses |
26,392,883.66 |
| Deferred Income Tax Assets |
69,921,192.91 |
| Other Non-Current Assets |
750,112,677.04 |
| Sub-Total of Non-Current Assets |
7,077,530,748.97 |
| Total Assets |
14,665,994,987.75 |
| Short-Term Loans |
2,859,881,386.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
798,438,980.93 |
| Accounts Payable |
1,124,647,009.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
48,377,617.33 |
| Taxes Payable |
107,213,744.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,986,250.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
18,340,891.63 |
| Sub-Total of Current Liabilities |
5,098,720,756.42 |
| Long-term Loans |
154,285,577.71 |
| Bonds Payable |
1,887,202,033.59 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
36,171,107.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,535,468,035.02 |
| Total Liabilities |
7,634,188,791.44 |
| Paid-In Capital(Or Share Stock) |
705,975,369.00 |
| Capital Surplus |
3,064,479,862.54 |
| Surplus Reserve |
264,154,209.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,707,255,475.00 |
| Minority Stockholder's Interest |
32,677,920.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,999,128,275.63 |
| Owner's Equity（Stockholder's Equity） |
7,031,806,196.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,665,994,987.75 |
